Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,000 | 5,364,000 | 5,460,000 | 4,644,000 | 13,488,000 |
| Depreciation Amortization | 1,480,000 | 1,404,000 | 1,429,000 | 1,286,000 | 1,158,000 |
| Income taxes - deferred | -214,000 | -2,098,000 | 289,000 | -82,000 | -119,000 |
| Accounts receivable | -1,171,000 | -218,000 | 480,000 | 754,000 | 1,192,000 |
| Accounts payable and accrued liabilities | 80,000 | -61,000 | -39,000 | -430,000 | 47,000 |
| Other Working Capital | -1,638,000 | -798,000 | -939,000 | 5,108,000 | 1,546,000 |
| Other Operating Activity | 9,542,000 | 5,551,000 | 1,720,000 | 618,000 | -265,000 |
| Operating Cash Flow | $8,168,000 | $9,144,000 | $8,400,000 | $11,898,000 | $17,047,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,403,000 | -534,000 | 15,625,000 | -5,053,000 | -10,880,000 |
| PPE Investments | -650,000 | -825,000 | -924,000 | -590,000 | -748,000 |
| Net Acquisitions | -25,920,000 | -4,251,000 | N/A | -10,426,000 | N/A |
| Purchase Of Investment | -455,000 | -1,773,000 | -156,000 | N/A | -357,000 |
| Other Investing Activity | 7,000 | -434,000 | -190,000 | 0 | 0 |
| Investing Cash Flow | $-14,615,000 | $-7,817,000 | $14,355,000 | $-16,069,000 | $-11,985,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,184,000 | 0 | N/A | 8,985,000 | 6,249,000 |
| Debt Repayment | -2,500,000 | -2,750,000 | -6,250,000 | -1,811,000 | -1,981,000 |
| Common Stock Issued | 256,000 | 209,000 | 289,000 | 234,000 | 208,000 |
| Common Stock Repurchased | -1,583,000 | -1,749,000 | -2,900,000 | -954,000 | -11,001,000 |
| Dividend Paid | -3,449,000 | -3,222,000 | -2,971,000 | -2,731,000 | -2,455,000 |
| Other Financing Activity | -138,000 | -122,000 | -486,000 | -330,000 | -745,000 |
| Financing Cash Flow | $770,000 | $-7,634,000 | $-12,318,000 | $3,393,000 | $-9,725,000 |
| Exchange Rate Effect | 43,000 | -2,000 | -85,000 | 137,000 | 41,000 |
| Beginning Cash Position | 11,631,000 | 17,940,000 | 7,588,000 | 8,229,000 | 12,851,000 |
| End Cash Position | 5,997,000 | 11,631,000 | 17,940,000 | 7,588,000 | 8,229,000 |
| Net Cash Flow | $-5,634,000 | $-6,309,000 | $10,352,000 | $-641,000 | $-4,622,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,168,000 | 9,144,000 | 8,400,000 | 11,898,000 | 17,047,000 |
| Capital Expenditure | -650,000 | -825,000 | -924,000 | -590,000 | -748,000 |
| Free Cash Flow | 7,518,000 | 8,319,000 | 7,476,000 | 11,308,000 | 16,299,000 |